These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 21839126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ, Du JZ, Sun TM, Yao YD, Zhang PZ, Song EW, Wang J.
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
    Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, Huang SY, Zhang PZ, Leong KW, Song EW, Wang J.
    ACS Nano; 2011 Feb 22; 5(2):1483-94. PubMed ID: 21204585
    [Abstract] [Full Text] [Related]

  • 4. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
    Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam DH.
    Bioconjug Chem; 2011 Dec 21; 22(12):2568-72. PubMed ID: 22070554
    [Abstract] [Full Text] [Related]

  • 5. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J.
    ACS Nano; 2012 Jun 26; 6(6):4955-65. PubMed ID: 22646867
    [Abstract] [Full Text] [Related]

  • 6. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J.
    Adv Healthc Mater; 2014 Nov 26; 3(11):1792-803. PubMed ID: 24947820
    [Abstract] [Full Text] [Related]

  • 7. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ, Zhang S, Yang Y, Zhang N, Wang W, Liu SY, Tian HW, Dai L, Xie Q, Zhao X, Wei YQ, Deng HX.
    Cancer Biother Radiopharm; 2011 Aug 26; 26(4):427-36. PubMed ID: 21797676
    [Abstract] [Full Text] [Related]

  • 8. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
    Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J.
    J Control Release; 2014 Oct 28; 192():114-21. PubMed ID: 25016158
    [Abstract] [Full Text] [Related]

  • 9. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.
    Biomacromolecules; 2009 Jan 12; 10(1):41-8. PubMed ID: 19072631
    [Abstract] [Full Text] [Related]

  • 10. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN.
    Acc Chem Res; 2012 Jul 17; 45(7):1163-71. PubMed ID: 22568781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.
    Eur J Pharm Biopharm; 2008 Nov 17; 70(3):718-25. PubMed ID: 18647651
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
    Wang HX, Yang XZ, Sun CY, Mao CQ, Zhu YH, Wang J.
    Biomaterials; 2014 Aug 17; 35(26):7622-34. PubMed ID: 24929619
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C, Zheng M, Gong P, Deng J, Yi H, Zhang P, Zhang Y, Liu P, Ma Y, Cai L.
    Biomaterials; 2013 Apr 17; 34(13):3431-8. PubMed ID: 23375952
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J, Feng SS, Wang S, Chen ZY.
    Int J Pharm; 2010 Nov 15; 400(1-2):194-200. PubMed ID: 20801205
    [Abstract] [Full Text] [Related]

  • 17. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.
    Biomaterials; 2012 Dec 15; 33(34):8893-905. PubMed ID: 22979990
    [Abstract] [Full Text] [Related]

  • 18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS, Yawata T, Honke K.
    Eur J Pharm Sci; 2014 Feb 14; 52():48-61. PubMed ID: 24178005
    [Abstract] [Full Text] [Related]

  • 19. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B, Liu BY, Cheng XH, Qu Y, Zhang XQ, Cai Q, Dai QB, Zhu ZG.
    Zhonghua Wai Ke Za Zhi; 2006 Jan 01; 44(1):40-4. PubMed ID: 16620646
    [Abstract] [Full Text] [Related]

  • 20. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
    Song WJ, Du JZ, Sun TM, Zhang PZ, Wang J.
    Small; 2010 Jan 01; 6(2):239-46. PubMed ID: 19924738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.